GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BIO-FD&C Co Ltd (XKRX:251120) » Definitions » Scaled Net Operating Assets

BIO-FD&C Co (XKRX:251120) Scaled Net Operating Assets : 0.31 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BIO-FD&C Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BIO-FD&C Co's operating assets for the quarter that ended in Mar. 2024 was ₩22,479 Mil. BIO-FD&C Co's operating liabilities for the quarter that ended in Mar. 2024 was ₩3,022 Mil. BIO-FD&C Co's Total Assets for the quarter that ended in Dec. 2023 was ₩62,813 Mil. Therefore, BIO-FD&C Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.31.


BIO-FD&C Co Scaled Net Operating Assets Historical Data

The historical data trend for BIO-FD&C Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-FD&C Co Scaled Net Operating Assets Chart

BIO-FD&C Co Annual Data
Trend Dec15 Dec16 Dec18 Dec19 Dec20 Dec21 Dec22
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.67 0.55 0.67 0.81 0.70

BIO-FD&C Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.28 0.30 0.31 0.31

Competitive Comparison of BIO-FD&C Co's Scaled Net Operating Assets

For the Biotechnology subindustry, BIO-FD&C Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-FD&C Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BIO-FD&C Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BIO-FD&C Co's Scaled Net Operating Assets falls into.



BIO-FD&C Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BIO-FD&C Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(18691.444-2642.247)/23040.032
=0.70

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=59035.811 - 40344.367
=18691.444

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=6058.43 - 0 - 3416.183
=2642.247

BIO-FD&C Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(22479.223-3021.675)/62812.541
=0.31

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=63951.451 - 41472.228
=22479.223

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4240.833 - 2.566 - 1216.592
=3021.675

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIO-FD&C Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BIO-FD&C Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-FD&C Co (XKRX:251120) Business Description

Traded in Other Exchanges
N/A
Address
30, Songdomirae-ro, Yeonsu-gu, 509-512, B07, A-dong, Smartvalley, Incheon, KOR
BIO-FD&C Co Ltd is engaged in dealing with anti-aging and health materials using sustainable bio-cultivation technology. Its products include Plant cell, Peptide, Herbal Extract and Biomolecule.

BIO-FD&C Co (XKRX:251120) Headlines

No Headlines